We invite you to take part in this survey about communication between patients and their physicians regarding inflammatory bowel disease (primarily Crohn’s disease and ulcerative colitis). This is a follow-up to a survey we conducted in 2018 about the unmet need in inflammatory bowel disease and we are opening it up to global input.
The Gastrointestinal Society and the Canadian Society of Intestinal Research represent inflammatory bowel disease (IBD) patients on a variety of healthcare fronts, including health policy. We have designed this survey to help us understand your opinions and outlook regarding the unmet need in treating IBD. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare professionals, and health policy decision-makers.
To complete this survey, you must have been diagnosed with inflammatory bowel disease (Crohn’s disease, ulcerative colitis, ulcerative proctitis, microscopic colitis, etc.).
Want to learn more about IBD?
We have several related articles that may be helpful:
- Inflammatory Bowel Disease
- Crohn’s Disease
- Ulcerative Colitis
- Short Bowel Syndrome
- Biologics and Biosimilars
- Survey Results: Biosimilars
- Biologic Coverage for IBD
- Therapeutic Drug Monitoring
- Medical Cannabis and IBD
- IBD and the Balanced Dinner Plate
- IBD & Pregnancy: Meeting the Challenge
- BadGut® Stories
- Living with IBD: Tips From Our Support Groups